These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 32248762)

  • 1. Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats.
    Li J; Minćzuk K; Massey JC; Howell NL; Roy RJ; Paul S; Patrie JT; Kramer CM; Epstein FH; Carey RM; Taegtmeyer H; Keller SR; Kundu BK
    J Am Heart Assoc; 2020 Apr; 9(7):e015154. PubMed ID: 32248762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Changes in Spontaneously Hypertensive Rat Hearts Precede Cardiac Dysfunction and Left Ventricular Hypertrophy.
    Li J; Kemp BA; Howell NL; Massey J; Mińczuk K; Huang Q; Chordia MD; Roy RJ; Patrie JT; Davogustto GE; Kramer CM; Epstein FH; Carey RM; Taegtmeyer H; Keller SR; Kundu BK
    J Am Heart Assoc; 2019 Feb; 8(4):e010926. PubMed ID: 30764689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compromised mitochondrial remodeling in compensatory hypertrophied myocardium of spontaneously hypertensive rat.
    Tang Y; Mi C; Liu J; Gao F; Long J
    Cardiovasc Pathol; 2014; 23(2):101-6. PubMed ID: 24388463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus.
    Rosa CM; Gimenes R; Campos DH; Guirado GN; Gimenes C; Fernandes AA; Cicogna AC; Queiroz RM; Falcão-Pires I; Miranda-Silva D; Rodrigues P; Laurindo FR; Fernandes DC; Correa CR; Okoshi MP; Okoshi K
    Cardiovasc Diabetol; 2016 Sep; 15(1):126. PubMed ID: 27585437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive Cardiac Metabolic Defects Accompany Diastolic and Severe Systolic Dysfunction in Spontaneously Hypertensive Rat Hearts.
    Li J; Minczuk K; Huang Q; Kemp BA; Howell NL; Chordia MD; Roy RJ; Patrie JT; Qureshi Z; Kramer CM; Epstein FH; Carey RM; Kundu BK; Keller SR
    J Am Heart Assoc; 2023 May; 12(10):e026950. PubMed ID: 37183873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction.
    Chen A; Li W; Chen X; Shen Y; Dai W; Dong Q; Li X; Ou C; Chen M
    BMC Cardiovasc Disord; 2016 Nov; 16(1):225. PubMed ID: 27855650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal evaluation of left ventricular substrate metabolism, perfusion, and dysfunction in the spontaneously hypertensive rat model of hypertrophy using small-animal PET/CT imaging.
    Hernandez AM; Huber JS; Murphy ST; Janabi M; Zeng GL; Brennan KM; O'Neil JP; Seo Y; Gullberg GT
    J Nucl Med; 2013 Nov; 54(11):1938-45. PubMed ID: 24092939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis.
    Kundu BK; Zhong M; Sen S; Davogustto G; Keller SR; Taegtmeyer H
    Cardiology; 2015; 130(4):211-20. PubMed ID: 25791172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.
    Purushothaman S; Sathik MM; Nair RR
    J Cardiovasc Pharmacol; 2011 Sep; 58(3):254-62. PubMed ID: 21654328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
    Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
    Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
    Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of medium-chain triglyceride (MCT) application to SHR on cardiac function, hypertrophy and expression of endothelin-1 mRNA and other genes.
    Shimojo N; Miyauchi T; Iemitsu M; Irukayama-Tomobe Y; Maeda S; Ohkubo T; Tanaka Y; Goto K; Yamaguchi I
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S181-5. PubMed ID: 15838274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations.
    Iemitsu M; Shimojo N; Maeda S; Irukayama-Tomobe Y; Sakai S; Ohkubo T; Tanaka Y; Miyauchi T
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H136-44. PubMed ID: 18456726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of concurrent training and N-acetylcysteine supplementation on cardiac remodeling and oxidative stress in middle-aged spontaneously hypertensive rats.
    Junqueira A; Gomes MJ; Lima ARR; Pontes THD; Rodrigues EA; Damatto FC; Depra I; Paschoareli GL; Pagan LU; Fernandes AAH; Oliveira-Jr SA; Pacagnelli FL; Okoshi MP; Okoshi K
    BMC Cardiovasc Disord; 2024 Aug; 24(1):409. PubMed ID: 39103770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Modulation by Medium-Chain Triglycerides Reduces Oxidative Stress and Ameliorates CD36-Mediated Cardiac Remodeling in Spontaneously Hypertensive Rat in the Initial and Established Stages of Hypertrophy.
    Saifudeen I; Subhadra L; Konnottil R; Nair RR
    J Card Fail; 2017 Mar; 23(3):240-251. PubMed ID: 27530817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart-bound adiponectin, not serum adiponectin, inversely correlates with cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
    Inoue T; Takemori K; Mizuguchi N; Kimura M; Chikugo T; Hagiyama M; Yoneshige A; Mori T; Maenishi O; Kometani T; Itoh T; Satou T; Ito A
    Exp Physiol; 2017 Nov; 102(11):1435-1447. PubMed ID: 28841247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
    Jang SW; Ihm SH; Choo EH; Kim OR; Chang K; Park CS; Kim HY; Seung KB
    Hypertension; 2014 Jun; 63(6):1228-34. PubMed ID: 24591339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
    Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.
    Yin M; van der Horst IC; van Melle JP; Qian C; van Gilst WH; Silljé HH; de Boer RA
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H459-68. PubMed ID: 21572014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver growth factor treatment restores cell-extracellular matrix balance in resistance arteries and improves left ventricular hypertrophy in SHR.
    Conde MV; Gonzalez MC; Quintana-Villamandos B; Abderrahim F; Briones AM; Condezo-Hoyos L; Regadera J; Susin C; Gomez de Diego JJ; Delgado-Baeza E; Diaz-Gil JJ; Arribas SM
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1153-65. PubMed ID: 21642499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.